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INTRODUCTION
Fulminant type 1 diabetes mellitus (FT1DM) is
a new subtype of type 1 diabetes mellitus (T1DM)
reported by Imagawa et al. in 2000 (1). FT1DM is
characterized by a very rapid onset and develops
due to nearly complete destruction of pancreatic β
cells (1, 2). FT1DM accounts for about 20% of T1
DM in Japanese patients (2). Moreover, in a nation-
wide survey in Japan, the most common form of
T1DM with onset during pregnancy has been shown
to be FT1DM (3). FT1DM that develops during
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pregnancy affects not only the mother, but also the
fetus, and is associated with a high rate of still-
births (4). Therefore, FT1DM developing during
pregnancy should be diagnosed and be treated im-
mediately.
In diabetic patients, glycation of various proteins
is known to be increased, and some of these gly-
cated proteins are thought to be involved in the on-
set and progression of chronic diabetic complica-
tions (5). Of these proteins, HbA1c is widely used
clinically as a marker of glycemic control (6). As
the half-life of serum albumin is shorter than that
of erythrocytes, glycated albumin (GA) is used as
a marker of plasma glucose levels over a shorter
period (about 2 weeks) (7-9). Thus, GA reflects
shorter term control of plasma glucose than HbA1c.
We previously reported that HbA1c is only mildly
elevated in FT1DM patients because of the abrupt
rise in plasma glucose, whereas GA is clearly ele-
vated (10). Therefore, the ratio of GA to HbA1c
(GA/HbA1c ratio) is elevated in FT1DM patients
at the diagnosis, being 3.2 in most FT1DM pa-
tients [using the HbA1c-Japan Diabetes Society
(JDS) value ;3.0 using the HbA1c-National Gly-
cohemoglobin Standardization Program (NGSP)
value]. However, in most patients with type 2 dia-
betes mellitus (T2DM), the GA/HbA1c ratio is3.2
(using the HbA1c-JDS value ;3.0 using the HbA1c-
NGSP value) (10).
From mid through late pregnancy, HbA1c lev-
els are increased (11, 12), whereas GA levels are
not changed (13, 14). This has been shown to be
due to iron deficiency (13, 14), which occurs in
most women in late pregnancy. Because HbA1c,
but not GA, is increased under the influence of
iron deficient conditions (15, 16), the GA/HbA1c
ratio is decreased from mid through late pregnancy
(13, 14).
In this study, we investigated whether the GA/
HbA1c ratio is also elevated in FT1DM patients with
onset during pregnancy compared with T2DM pa-
tients under these situations.
PATIENTS AND METHODS
Patients
This study included 7 patients with FT1DM with
onset during pregnancy (P-FT1DM), all cases by
JDS’s Comittee on Research of T1DM or reported
cases, in whom HbA1c and GA were simultaneously
measured at initial evaluation (Table 1). As con-
trols, we included 10 patients with untreated T2DM
discovered during pregnancy (P-T2DM) and 9
non-pregnant women with untreated T2DM (NP-
T2DM) evaluated at Kinki Central Hospital, in
whom HbA1c and GA were simultaneously meas-
ured before treatment. T2DM was diagnosed based
on JDS criteria (17). In pregnancy, oral glucose
tolerance test (OGTT) was performed for diagno-
sis of diabetes mellitus. All study patients satis-
fied HbA1c8.3% (using the JDS value ;8.7% us-
ing NGSP value), one of the diagnostic criteria for
FT1DM (18). Patients with liver, renal or thyroid
disease and those taking glucocorticoid therapy
were excluded. For the P-T2DM patients, patients
with gestational diabetes mellitus (19) were ex-
cluded. The institutional review board approved this
Table 1 Clinical characteristics of study patients in this study
Fulminant type 1 diabetes
with onset in pregnancy
Type 2 diabetes with
onset in pregnancy
Type 2 diabetes in
non-pregnant women
(P-FT1DM) (P-T2DM) (NP-T2DM)
Total number 7 10 9
Age (years) 29.63.0 35.25.0# 49.418.1#
Body mass index (kg/m2) 19.31.8 27.76.4## 23.64.4#
Duration of pregnancy (weeks) 20.312.6 (5-36) 18.08.8 (6-36) -
Disease duration (days) 2.62.9 - -
Plasma glucose (mg/dl) 764213* (505-983) 13562**, ### (81-227) 13524** (113-181)
HbA1c (%) 6.00.4 (5.6 -6.5) 6.50.7 (5.5 -7.9) 7.20.7## (6.4 -8.3)
GA (%) 20.51.9 (17.1-22.9) 17.53.4 (13.2-23.1) 19.11.7 (17.6-23.0)
# : p0.05, ## : p0.01, ### : p0.001 vs. P-FT1DM, * : randomly measured plasma glucose,
** : fasting plasma glucose, parentheses denote range
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study, and all T2DM patients as control group pro-
vided written informed consent.
Laboratory analysis
HbA1c was measured by high performance liq-
uid chromatography. The value for HbA1c (%) was
estimated as an NGSP equivalent value (%) calcu-
lated by the formula HbA1c (%)=HbA1c (JDS) (%)+
0.4%, considering the relational expression of HbA1c
(JDS) (%), as measured by the previous Japanese
standard substance and measurement methods and
HbA1c (NGSP) (17). Serum GA was determined by
an enzymatic method using albumin-specific pro-
teinase, ketoamine oxidase and albumin assay re-
agent (Lucica GA-L ; Asahi Kasei Pharma Co.,
Tokyo, Japan) (20).
Statistical analysis
All data are presented as meansSD. For statis-
tical analyses, the Mann-Whitney U test was used
to compare two groups. Simple regression analyses
were employed in order to assess the association
between continuous variables. A p value of0.05
was considered to be statistically significant.
RESULTS
The P-FT1DM patients were significantly younger
than the P-T2DM patients and the NP-T2DM pa-
tients (Table 1). Body mass index (BMI) in the P-
FT1DM patients was significantly lower than that in
the P-T2DM patients and the NP-T2DM patients.
Randomly measured plasma glucose levels in the
P-FT1DM patients were markedly higher than that
in the P-T2DM patients and in the NP-T2DM pa-
tients. HbA1c levels in the P-FT1DM patients and
that in the P-T2DM patients did not significantly
differ. It was significantly lower in the P-FT1DM
patients than in the NP-T2DM patients. On the
other hand, GA did not significantly differ among the
3 groups (Table 1).
In each group, HbA1c was significantly correlated
with GA, but the regression line for HbA1c and
GA in the P-FT1DM patients showed an upward
shift in comparison with that in the P-T2DM pa-
tients and that in the NP-T2DM patients (Fig. 1).
The GA/HbA1c ratio in the P-FT1DM patients was
significantly higher compared with the P-T2DM
patients and the NP-T2DM patients (P-FT1DM :
3.40.2 vs. P -T2DM : 2.70.4 ; p0.01, vs. NP -
T2DM : 2.70.2 ; p0.01) (Fig. 2). The GA/HbA1c
ratio was3.0 in all P-FT1DM patients, whereas
that was3.0 in 8 of 10 P-T2DM patients and in all
NP-T2DM patients.
DISCUSSION
In T2DM patients, the GA/HbA1c ratio is re-
ported to be about 3.0, with a range of 2.0 to 4.0 (9,
21). In diabetic patients with poor glycemic control,
Figure 1 Correlation between HbA1c and GA in each group.
Relationship between HbA1c and GA in the patients with fulmi-
nant type 1 diabetes mellitus with onset during pregnancy (P-
FT1DM) (closed circles), the patients with type 2 diabetes mel-
litus with onset during pregnancy (P-T2DM) (open circles), and
the patients with type 2 diabetes mellitus in non-pregnant women
(NP-T2DM) (open squares). Regression line is shown for each
group.
Figure 2 The GA/HbA1c ratio in each group.
The GA/HbA1c ratio in the patients with fulminant type 1 dia-
betes mellitus with onset during pregnancy (P-FT1DM) (closed
circles), the patients with type 2 diabetes mellitus with onset
during pregnancy (P-T2DM) (open circles), and the patients with
type 2 diabetes mellitus in non-pregnant women (NP-T2DM)
(open squares). MeanSD values and individual values of the
GA/HbA1c ratio in each group are shown. Dotted line indicates
the GA/HbA1c ratio of 3.0.
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when plasma glucose rapidly improves, the GA/
HbA1c ratio is decreased because the degree of
decrease in GA is larger than that in HbA1c (8, 9).
Conversely, when glycemic control rapidly worsens,
the degree of increase in GA is also expected to be
larger compared with HbA1c. In this study, based
on a higher GA/HbA1c ratio in the FT1DM patients
with onset during pregnancy, a high GA/HbA1c
ratio at the time of acute plasma glucose elevation
could be confirmed.
FT1DM with onset during pregnancy must be
diagnosed and be treated immediately. In most pa-
tients with FT1DM, its diagnosis is relatively easy
due to the presence of marked hyperglycemia and
ketoacidosis in addition to hyperglycemic symp-
toms. However, only mildly elevated plasma glucose
has been reported at the time of onset in some
patients with FT1DM (22). Based on the findings
in this study, if HbA1c is8.9% and the GA/HbA1c
ratio is 3.0 in diabetic patients with onset during
pregnancy, FT1DM is strongly suspected.
Because HbA1c is increased under the influence
of iron deficiency, which occurs in most women in
late pregnancy, the GA/HbA1c ratio is decreased
from mid through late pregnancy (13, 14). Although
the GA/HbA1c ratio (3.40.2) in the P-FT1DM pa-
tients was slightly lower than that (3.70.5) in the
FT1DM patients without pregnancy described pre-
viously (10), there was no significant difference be-
tween both groups. Thus, the influence of iron de-
ficiency in pregnancy on the GA/HbA1c ratio is neg-
ligible compared with the influence of FT1DM.
BMI in the P-FT1DM patients was significantly
lower than that in the P-T2DM patients and the NP-
T2DM patients. We reported that BMI negatively
influences GA, but not HbA1c, in non-diabetic sub-
jects and diabetic patients (21, 23). The differences
of BMI might influence the GA/HbA1c ratio in each
group. However, similar results were obtained when
the GA/HbA1c ratio was adjusted by BMI (data not
shown).
Because P-FT1DM is a relatively rare condition,
the number of P-FT1DM patients was small in this
study. In the future, the GA/HbA1c ratio in P-FT1
DM patients should be examined using a large num-
ber of patients.
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